PRospectIve ObseRvatIonal mulTicenter study of patients with arterial hYpertension and CKD in the population of Russia

Trial Identifier:	D1843R00360
Sponsor:	AstraZeneca
NCTID::	NCT06372431
Start Date:	April 2024
Primary Completion Date:	October 2025
Study Completion Date:	October 2025

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Russia	Ryazan, Russia
Russia	Ufa, Russia
Russia	Yaroslavl, Russia

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.